SPIDER TOXINS AFFECTING GLUTAMATE RECEPTORS - POLYAMINES IN THERAPEUTIC NEUROCHEMISTRY

被引:88
|
作者
USHERWOOD, PNR [1 ]
BLAGBROUGH, IS [1 ]
机构
[1] UNIV BATH, SCH PHARM & PHARMACOL, BATH BA2 7AY, AVON, ENGLAND
关键词
D O I
10.1016/0163-7258(91)90012-B
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Polyamine amide toxins obtained from venoms of spiders and wasps interact selectively with ionotropic glutamate receptors (GLU-R) of vertebrate central nervous systems. The sites and modes of action of these polyamide amide toxins are reviewed with particular reference to their structure-activity relationships. Qualitatively, their effects on GLU-R are identical to those exerted by polyamines such as spermine, but the polyamine amides are more potent. These compounds (a) potentiate and (b) antagonize GLU-R, the latter arising through open channel block. For the N-methyl-D-aspartate receptor this non-competitive antagonism probably arises through binding of toxin to the Mg2+ site(s) located in the channel gated by this receptor. Similarities and differences between GLU-R in vertebrates and in invertebrates with respect to their interactions with polyamines and polyamine amide toxins are discussed. In both groups the low specificity of these compounds is illustrated by their antagonism at nicotinic acetylcholine receptors in addition to GLU-R. Electrophysiological studies, including those employing Xenopus oocytes, are reviewed and future prospects for the use of polyamine amides in therapy are discussed.
引用
收藏
页码:245 / 268
页数:24
相关论文
共 50 条
  • [21] Glutamate metabotropic receptors as therapeutic targets in epilepsy
    Meldrum, BS
    Conn, PJ
    Merlin, LR
    Shinnick-Gallagher, P
    Chapman, AG
    EPILEPSIA, 1999, 40 : 1 - 1
  • [22] Ligands for glutamate receptors:: Design and therapeutic prospects
    Bräuner-Osborne, H
    Egebjerg, J
    Nielsen, EO
    Madsen, U
    Krogsgaard-Larsen, P
    JOURNAL OF MEDICINAL CHEMISTRY, 2000, 43 (14) : 2609 - 2645
  • [23] Glutamate and Its Receptors as Therapeutic Targets for Migraine
    Jan Hoffmann
    Andrew Charles
    Neurotherapeutics, 2018, 15 : 361 - 370
  • [24] Therapeutic promise and principles Metabotropic glutamate receptors
    Maiese, Kenneth
    Chong, Zhao Zhong
    Shang, Yan Chen
    Hou, Jinling
    OXIDATIVE MEDICINE AND CELLULAR LONGEVITY, 2008, 1 (01) : 1 - 14
  • [25] Ionotropic Glutamate Receptors as Therapeutic Targets in Schizophrenia
    Coyle, Joseph T.
    Tsai, Guochuan
    Goff, Donald C.
    CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2002, 1 (02) : 183 - 189
  • [26] Glutamate Receptors: A Therapeutic Target in Batten Disease
    Pearce, David
    MOLECULAR GENETICS AND METABOLISM, 2012, 105 (02) : S51 - S51
  • [27] Metabotropic glutamate receptors - different therapeutic perspectives
    Wolfarth, S
    AMINO ACIDS, 2000, 19 (01) : 79 - 80
  • [28] Glutamate and Its Receptors as Therapeutic Targets for Migraine
    Hoffmann, Jan
    Charles, Andrew
    NEUROTHERAPEUTICS, 2018, 15 (02) : 361 - 370
  • [29] New therapeutic frontiers for metabotropic glutamate receptors
    Niswender, CM
    Jones, CK
    Conn, PJ
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2005, 5 (09) : 847 - 857
  • [30] Metabotropic glutamate receptors as therapeutic targets for schizophrenia
    Vinson, Paige N.
    Conn, P. Jeffrey
    NEUROPHARMACOLOGY, 2012, 62 (03) : 1461 - 1472